Want to see TSE:ASTI full AI Analyst Report?
Total Valuation
Aquarius Surgical Technologies has a market cap or net worth of C$275.99K. The enterprise value is C$6.84M.
Market CapC$275.99K
Enterprise ValueC$6.84M
Share Statistics
Aquarius Surgical Technologies has 27,599,173 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,599,173
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aquarius Surgical Technologies’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is -78.23%.
Return on Equity (ROE)0.20
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-78.23%
Return on Capital Employed (ROCE)-2.60
Revenue Per Employee30.40K
Profits Per Employee-389.08K
Employee Count3
Asset Turnover0.05
Inventory Turnover2.19
Valuation Ratios
The current PE Ratio of Aquarius Surgical Technologies is ―. Aquarius Surgical Technologies’s PEG ratio is -0.00879.
PE Ratio―
PS Ratio6.05
PB Ratio-0.10
Price to Fair Value-0.10
Price to FCF-1.44
Price to Operating Cash Flow-1.59
PEG Ratio-0.00879
Income Statement
In the last 12 months, Aquarius Surgical Technologies had revenue of 91.20K and earned -1.17M in profits. Earnings per share was -0.04.
Revenue91.20K
Gross Profit47.31K
Operating Income-545.56K
Pretax Income-1.17M
Net Income-1.17M
EBITDA-832.81K
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -173.46K and capital expenditures -2.00, giving a free cash flow of -173.46K billion.
Operating Cash Flow-173.46K
Free Cash Flow-173.46K
Free Cash Flow per Share>-0.01
Dividends & Yields
Aquarius Surgical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.70
52-Week Price Change-60.00%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)32.06
Average Volume (3m)6.90K
Important Dates
Aquarius Surgical Technologies upcoming earnings date is Aug 3, 2026, TBA (Confirmed).
Last Earnings DateFeb 24, 2026
Next Earnings DateAug 3, 2026
Ex-Dividend Date―
Financial Position
Aquarius Surgical Technologies as a current ratio of 0.06, with Debt / Equity ratio of -8.85%
Current Ratio0.06
Quick Ratio0.05
Debt to Market Cap11.62
Net Debt to EBITDA-7.76
Interest Coverage Ratio-1.72
Taxes
In the past 12 months, Aquarius Surgical Technologies has paid 1.51K in taxes.
Income Tax1.51K
Effective Tax Rate>-0.01
Enterprise Valuation
Aquarius Surgical Technologies EV to EBITDA ratio is -8.42, with an EV/FCF ratio of -18.30.
EV to Sales76.91
EV to EBITDA-8.42
EV to Free Cash Flow-18.30
EV to Operating Cash Flow-18.30
Balance Sheet
Aquarius Surgical Technologies has C$10.38K in cash and marketable securities with C$571.18K in debt, giving a net cash position of -C$560.80K billion.
Cash & Marketable SecuritiesC$10.38K
Total DebtC$571.18K
Net Cash-C$560.80K
Net Cash Per Share-C$0.02
Tangible Book Value Per Share-C$0.21
Margins
Gross margin is 41.34%, with operating margin of -598.19%, and net profit margin of -1279.85%.
Gross Margin41.34%
Operating Margin-598.19%
Pretax Margin-1278.19%
Net Profit Margin-1279.85%
EBITDA Margin-913.15%
EBIT Margin-945.11%
Analyst Forecast
The average price target for Aquarius Surgical Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-31.81%
EPS Growth Forecast-28.35%